{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:44:15Z","timestamp":1793148255188,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1097\/md.0000000000001350","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T22:21:00Z","timestamp":1443046860000},"page":"e1350","source":"Crossref","is-referenced-by-count":19,"title":["Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation"],"prefix":"10.1097","volume":"94","author":[{"given":"Chih-Hsiang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Kung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Han","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0012.2000.140101.x","article-title":"Central nervous system complications in liver transplant recipients-incidence, timing, and long-term follow-up","volume":"14","author":"Bronster","year":"2000","journal-title":"Clin Transplant"},{"key":"R2-5-20210226","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/01.WNL.0000089487.42870.C6","article-title":"Neurologic complications of liver transplantation in adults","volume":"61","author":"Lewis","year":"2003","journal-title":"Neurology"},{"key":"R3-5-20210226","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4254\/wjh.v5.i8.409","article-title":"Neurologic complications after liver transplantation","volume":"5","author":"\u017divkovi\u0107","year":"2013","journal-title":"World J Hepatol"},{"key":"R4-5-20210226","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/157015910792246254","article-title":"Antiepileptic drug interactions - principles and clinical implications","volume":"8","author":"Johannessen","year":"2010","journal-title":"Curr Neuropharmacol"},{"key":"R5-5-20210226","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"R6-5-20210226","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.seizure.2010.05.008","article-title":"Antiepileptic treatment in patients with epilepsy and other comorbidities","volume":"19","author":"Ruiz-Gimenez","year":"2010","journal-title":"Seizure"},{"key":"R7-5-20210226","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy","volume":"93","author":"Tseng","year":"2014","journal-title":"Medicine (Baltimore"},{"key":"R8-5-20210226","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.seizure.2005.12.009","article-title":"Antiepileptic drugs and liver disease","volume":"15","author":"Ahmed","year":"2006","journal-title":"Seizure"},{"key":"R9-5-20210226","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00134-005-2695-0","article-title":"Pharmacokinetic interaction between valproic acid and meropenem","volume":"31","author":"Clause","year":"2005","journal-title":"Intensive Care Med"},{"key":"R10-5-20210226","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R11-5-20210226","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000\u200amg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"R12-5-20210226","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs: scientific review","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"key":"R13-5-20210226","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"key":"R14-5-20210226","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/01.WNL.0000154598.03596.40","article-title":"Levetiracetam for seizures after liver transplantation","volume":"64","author":"Glass","year":"2005","journal-title":"Neurology"},{"key":"R15-5-20210226","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.47.6.1523","article-title":"Causes and outcome of seizures in liver transplant recipients","volume":"47","author":"Wijdicks","year":"1996","journal-title":"Neurology"},{"key":"R16-5-20210226","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1528-1157.1987.tb05768.x","article-title":"Hepatic considerations in the use of antiepileptic drugs","volume":"28","author":"Dreifuss","year":"1987","journal-title":"Epilepsia"},{"key":"R17-5-20210226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"5","author":"Gugler","year":"1980","journal-title":"Clin Pharmacokinet"},{"key":"R18-5-20210226","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1081\/CLT-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"R19-5-20210226","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1756285615578406","article-title":"A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizures","volume":"8","author":"Chung","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"key":"R20-5-20210226","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/13543776.2013.782394","article-title":"Anticonvulsant\/antiepileptic carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Aggarwal","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"R21-5-20210226","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40262-013-0107-0","article-title":"Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment","volume":"53","author":"Anderson","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"R22-5-20210226","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0041-1345(03)00361-0","article-title":"Levetiracetam monotherapy for liver transplant patients with seizures","volume":"35","author":"Chabolla","year":"2003","journal-title":"Transplant Proc"},{"key":"R23-5-20210226","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1528-1157.2003.25302.x","article-title":"Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid","volume":"44","author":"Coupez","year":"2003","journal-title":"Epilepsia"},{"key":"R24-5-20210226","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00228-003-0655-6","article-title":"Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers","volume":"59","author":"Strolin Benedetti","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"R25-5-20210226","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.yebeh.2008.04.025","article-title":"Levetiracetam monotherapy for late poststroke seizures in the elderly","volume":"13","author":"Kutlu","year":"2008","journal-title":"Epilepsy Behav"},{"key":"R27-5-20210226","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.eplepsyres.2008.03.002","article-title":"Thrombocytopenia during levetiracetam therapy","volume":"80","author":"Meschede","year":"2008","journal-title":"Epilepsy Res"},{"key":"R28-5-20210226","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/j.1528-1167.2010.02788.x","article-title":"Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study","volume":"51","author":"Sahaya","year":"2010","journal-title":"Epilepsia"},{"key":"R29-5-20210226","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.0013-9580.2004.64903.x","article-title":"Levetiracetam-induced thrombocytopenia","volume":"45","author":"Kimland","year":"2004","journal-title":"Epilepsia"},{"key":"R30-5-20210226","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00296-0","article-title":"A systematic review of the safety profile of levetiracetam: a new antiepileptic drug","volume":"47","author":"French","year":"2001","journal-title":"Epilepsy Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:48:24Z","timestamp":1620960504000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201509040-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001350","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}